Living your life with prostate cancer
Prostate cancer is common and may be diagnosed early.
It’s important to understand your disease to help make treatment decisions with your healthcare provider. There are many factors to consider, from the type of cancer you have to the clinical study results for your medication.
What is metastatic castration-sensitive prostate cancer (mCSPC)?
Prostate cancer that HAS SPREAD to other parts of the body and STILL RESPONDS to a medical or surgical treatment that lowers testosterone. This is called metastatic castration-sensitive prostate cancer, or mCSPC.
The most common sites where prostate cancer can spread are bones, adrenal glands, liver, and lungs.
What is non-metastatic castration-resistant prostate cancer (nmCRPC)?
Prostate cancer that HAS NOT SPREAD to other parts of the body and NO LONGER responds to a medical or surgical treatment that lowers testosterone. This is called non-metastatic castration-resistant prostate cancer, or nmCRPC.
Black men and prostate cancer: prostate and total health are tied together
We work hard to provide for ourselves and those around us. No matter the obstacles, we find a way to persevere. But something is threatening to hold us back—prostate cancer.
When it comes to prostate cancer, it’s about “talking the talk and walking the walk” if we’re going to change the story for Black men. We all win if we learn about prostate cancer and invest in our health.
Personalized Support. From People Who Care.
Once you and your doctor have decided that ERLEADA® is right for you, you have access to a free, personalized support program that connects you with a dedicated Care Navigator to help you get started with your treatment and stay on track.
Your personal Care Navigator is just a phone call away.
You can also call us at 844-NAV-1234 (844-628-1234),
Monday through Friday, 8:30 AM - 8:30 PM ET
Patient Support from Janssen Compass™